Fate Therapeutics

FATE • NASDAQ • Stock Fundamentals

Fate Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Bahram Valamehr, with a market cap of $250.6M.

Market Cap$250.6M

Employees181.0

CEOBahram Valamehr

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026

Next EarningsAug 11, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Fate Therapeutics

Fate Therapeutics (FATE) has a market capitalization of $250.6M and trades on NASDAQ.

Fate Therapeutics has approximately 181 employees.